Chongqing Taiji Industry Group Co Ltd banner
C

Chongqing Taiji Industry Group Co Ltd
SSE:600129

Watchlist Manager
Chongqing Taiji Industry Group Co Ltd
SSE:600129
Watchlist
Price: 16.05 CNY -0.37% Market Closed
Market Cap: ¥8.9B

Chongqing Taiji Industry Group Co Ltd
Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Chongqing Taiji Industry Group Co Ltd
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
C
Chongqing Taiji Industry Group Co Ltd
SSE:600129
Operating Expenses
-¥2.7B
CAGR 3-Years
22%
CAGR 5-Years
10%
CAGR 10-Years
-2%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Expenses
-¥7B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Expenses
-¥18.7B
CAGR 3-Years
-10%
CAGR 5-Years
-1%
CAGR 10-Years
-13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Expenses
-¥7.1B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Zhejiang Nhu Co Ltd
SZSE:002001
Operating Expenses
-¥2B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-12%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Expenses
-¥1.8B
CAGR 3-Years
-38%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
No Stocks Found

Chongqing Taiji Industry Group Co Ltd
Glance View

Market Cap
8.9B CNY
Industry
Pharmaceuticals

Amidst the sprawling urban landscape of Chongqing, a city often enveloped in a mystical cloak of fog, stands Chongqing Taiji Industry Group Co Ltd., a distinguished entity in the realm of pharmaceuticals. Commanding a legacy that spans over a century, Taiji Industry has mastered the delicate fusion of traditional Chinese medicine with modern pharmaceutical processes. This synthesis has propelled the company to the forefront of China's healthcare sector. The company’s operations revolve around robust research and development, manufacturing, and distribution, focusing on a diverse array of pharmaceutical products, health supplements, and TCM (Traditional Chinese Medicine) remedies. Seamlessly integrating innovation with traditional wisdom, the group has built an extensive portfolio catering to a wide range of medical needs, from cardiovascular treatments to neurological supports. Financially, Taiji Industry's prowess is underpinned by its diverse revenue streams, primarily flowing from its broad spectrum of medicinal drugs and health products. The company has capitalized on its established brand and extensive distribution networks, which span across the vast Chinese landscape and extend their reach into international markets. Their stronghold in distribution is further solidified by strategic collaborations with healthcare providers and retail pharmacy chains, ensuring reliable market penetration and accessibility to the end consumer. This well-oiled machine not only secures Taiji's position as a major pharmaceutical player but also drives its financial growth, allowing the company to invest continuously in innovation, quality enhancement, and market expansion. The synergistic blend of tradition and modernity continues to propel Taiji Industry through the ever-evolving pharmaceutical landscape.

Intrinsic Value
22.89 CNY
Undervaluation 30%
Intrinsic Value
Price ¥16.05
C

See Also

What is Chongqing Taiji Industry Group Co Ltd's Operating Expenses?
Operating Expenses
-2.7B CNY

Based on the financial report for Dec 31, 2025, Chongqing Taiji Industry Group Co Ltd's Operating Expenses amounts to -2.7B CNY.

What is Chongqing Taiji Industry Group Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-2%

Over the last year, the Operating Expenses growth was 38%. The average annual Operating Expenses growth rates for Chongqing Taiji Industry Group Co Ltd have been 22% over the past three years , 10% over the past five years , and -2% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett